危重患者泛耐藥鮑氏不動桿菌定植與感染預防控制研究
發(fā)布時間:2018-05-08 01:15
本文選題:危重患者 + 泛耐藥鮑氏不動桿菌。 參考:《中華醫(yī)院感染學雜志》2016年02期
【摘要】:目的研究住院危重患者泛耐藥鮑氏不動桿菌的定植和感染,加強預防控制,降低其定植率與感染率。方法選擇2013年1月-2015年3月泛耐藥鮑氏不動桿菌定植與感染的住院危重患者150例為感染組,選擇同期未感染泛耐藥鮑氏不動桿菌的住院危重患者150例為對照組,比較兩組患者的臨床資料,分析泛耐藥鮑氏不動桿菌的分布及科室來源;采用SPSS20.0軟件對數(shù)據(jù)進行統(tǒng)計分析。結(jié)果感染組患者的ICU住院時間(33.82±13.74)d,APACEⅡ評分為(20.13±6.58)分,其中有98例行機械通氣占65.33%,死亡51例病死率34.00%,其各方面均明顯高于對照組,差異有統(tǒng)計學意義(P0.05);感染患者共分離出162株泛耐藥鮑氏不動桿菌,主要分布于痰液中;150例泛耐藥鮑氏不動桿菌感染患者中有44例為院外帶入,其余以急診科為主。結(jié)論住院危重患者泛耐藥鮑氏不動桿菌的定植和感染與患者的ICU住院時間、APACEⅡ評分、機械通氣等有關,應加強管理,降低其定植率和感染率。
[Abstract]:Objective to study the colonization and infection of Acinetobacter baumannii in critically ill inpatients, strengthen prevention and control, and reduce the colonization rate and infection rate. Methods from January 2013 to March 2015, 150 critically ill patients with pan-drug-resistant Acinetobacter baumannii colonization and infection were selected as infection group and 150 patients without pan-resistant Acinetobacter baumannii as control group. The clinical data of the two groups were compared and the distribution and source of Acinetobacter baumannii were analyzed. The data were analyzed by SPSS20.0 software. Results the hospitalization time of ICU in the infected group was 33.82 鹵13.74 days and the score of APACE 鈪,
本文編號:1859302
本文鏈接:http://sikaile.net/huliyixuelunwen/1859302.html
最近更新
教材專著